These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Modulation of vascular and cardiac contractile protein regulatory mechanisms by calmodulin inhibitors and related compounds. Silver PJ, Pinto PB, Dachiw J. Biochem Pharmacol; 1986 Aug 01; 35(15):2545-51. PubMed ID: 2943284 [Abstract] [Full Text] [Related]
3. Block of gating currents related to K+ channels as a mechanism of action of clofilium and d-sotalol in isolated guinea-pig ventricular heart cells. Malécot CO, Argibay JA. Br J Pharmacol; 1999 Sep 01; 128(2):301-12. PubMed ID: 10510439 [Abstract] [Full Text] [Related]
4. Modulation of protein kinase C activity by amiodarone and desethylamiodarone. Vig PJ, Desaiah D. Neurotoxicology; 1991 Sep 01; 12(3):595-601. PubMed ID: 1745442 [Abstract] [Full Text] [Related]
5. Modulation of calmodulin properties by amiodarone and its major metabolite desethylamiodarone. Vig PJ, Yallapragada PR, Kodavanti PR, Desaiah D. Pharmacol Toxicol; 1991 Jan 01; 68(1):26-33. PubMed ID: 1848930 [Abstract] [Full Text] [Related]
6. Hemodynamic effects of antiarrhythmic compounds: intrinsic effects and autonomic modulation. Hoffmeister HM, Beyer ME, Seipel L. Am J Cardiol; 1997 Oct 23; 80(8A):24G-30G. PubMed ID: 9354409 [Abstract] [Full Text] [Related]
8. Influences of rapid pacing-induced electrical remodeling on pharmacological manipulation of the atrial refractoriness in rabbits. Chiba T, Kondo N, Takahara A. J Pharmacol Sci; 2016 Mar 23; 130(3):170-6. PubMed ID: 27032905 [Abstract] [Full Text] [Related]
10. Comparative antiarrhythmic and electrophysiological effects of drugs known to inhibit calmodulin (TFP, W7 and bepridil). Barron E, Marshall RJ, Martorana M, Winslow E. Br J Pharmacol; 1986 Nov 23; 89(3):603-12. PubMed ID: 3492234 [Abstract] [Full Text] [Related]
11. Electrophysiological effects of a novel, short-acting and potent ester derivative of amiodarone, ATI-2001, in guinea pig isolated heart. Raatikainen MJ, Napolitano CA, Druzgala P, Dennis DM. J Pharmacol Exp Ther; 1996 Jun 23; 277(3):1454-63. PubMed ID: 8667210 [Abstract] [Full Text] [Related]
12. Effects of class III antiarrhythmic drugs on the Na(+)-activated K+ channels in guinea-pig ventricular cells. Mori K, Saito T, Masuda Y, Nakaya H. Br J Pharmacol; 1996 Sep 23; 119(1):133-41. PubMed ID: 8872366 [Abstract] [Full Text] [Related]
17. Arrhythmia control by prolonging repolarization: the concept and its potential therapeutic impact. Singh BN. Eur Heart J; 1993 Nov 01; 14 Suppl H():14-23. PubMed ID: 7904934 [Abstract] [Full Text] [Related]
18. Short- and long-term inhibition of cardiac inward-rectifier potassium channel current by an antiarrhythmic drug bepridil. Ma F, Takanari H, Masuda K, Morishima M, Ono K. Heart Vessels; 2016 Jul 01; 31(7):1176-84. PubMed ID: 26498939 [Abstract] [Full Text] [Related]
19. Effects of MDL 11,939 on action potential and contractile force in cardiac tissues: a comparison with bretylium, clofilium, and sotalol. Li T, Carr AA, Dage RC. J Cardiovasc Pharmacol; 1990 Dec 01; 16(6):917-23. PubMed ID: 1704984 [Abstract] [Full Text] [Related]
20. [Class III antiarrhythmic drugs]. Aiba T, Kamakura S. Nihon Rinsho; 1996 Aug 01; 54(8):2125-31. PubMed ID: 8810787 [Abstract] [Full Text] [Related] Page: [Next] [New Search]